We are live on ! Find out more
ALPN

Alpine Immune Sciences Inc

Delisted

ALPN was delisted on the 17th of May, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$36.2M +$2.32M +290,747 +7%
O
2
OrbiMed
New York
$31.5M
GPP
3
Great Point Partners
Connecticut
$28.9M +$821K +103,043 +3%
LCM
4
Lynx1 Capital Management
Puerto Rico
$24.2M +$79.7K +10,000 +0.3%
FLSM
5
Frazier Life Sciences Management
California
$23.1M
PBA
6
Paradigm Biocapital Advisors
New York
$17.9M
OFM
7
Omega Fund Management
Massachusetts
$15.7M
BlackRock
8
BlackRock
New York
$12M +$925K +116,060 +8%
Vanguard Group
9
Vanguard Group
Pennsylvania
$10.6M +$73.3K +9,206 +0.7%
CC
10
Commodore Capital
New York
$10.2M
OCA
11
Octagon Capital Advisors
New York
$9.28M -$183K -23,000 -2%
AG
12
Artal Group
Luxembourg
$9.21M
APM
13
Avidity Partners Management
Texas
$7.64M -$308K -38,700 -4%
BI
14
BVF Inc
California
$6.63M -$2.21M -277,601 -24%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$4.29M +$561K +70,457 +15%
State Street
16
State Street
Massachusetts
$2.68M +$345K +43,253 +14%
Renaissance Technologies
17
Renaissance Technologies
New York
$2.55M -$20.7K -2,600 -0.8%
TCM
18
TCG Crossover Management
California
$1.95M
AAA
19
Affinity Asset Advisors
New York
$1.91M
SFM
20
Sphera Funds Management
Israel
$1.54M
GTC
21
Ghost Tree Capital
New York
$1.54M +$1.59M +200,000 New
Northern Trust
22
Northern Trust
Illinois
$1.5M +$19.2K +2,415 +1%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$1.08M +$1.11M +139,672 New
HS
24
HighVista Strategies
Massachusetts
$697K +$719K +90,287 New
Bank of New York Mellon
25
Bank of New York Mellon
New York
$554K -$93.9K -11,785 -14%